Log in or Sign up for Free to view tailored content for your specialty!
Genitourinary Cancer News
Menu calorie labeling may reduce obesity-related cancer burden, health care costs
The 2018 introduction of calorie labels to restaurant menus appears to have yielded a net reduction in caloric intake of 20 to 60 calories per meal among Americans, potentially reducing risk for obesity-associated cancers.
Agent Orange exposure linked to increased risk for bladder cancer among Vietnam veterans
Men exposed to Agent Orange during their military service had a modestly increased risk for bladder cancer, results of a retrospective study of Vietnam veterans showed.
Log in or Sign up for Free to view tailored content for your specialty!
Cabozantinib plus nivolumab effective in advanced non-clear cell RCC
CHICAGO – Cabozantinib plus nivolumab showed promising efficacy in patients with papillary, unclassified or translocation-associated renal cell carcinoma, according to updated phase 2 study results presented at ASCO Annual Meeting.
Avelumab maintenance shows long-term safety in patients with advanced urothelial carcinoma
CHICAGO — Post-hoc analyses of the JAVELIN Bladder 100 trial confirmed the acceptable long-term safety of avelumab first-line maintenance for advanced urothelial carcinoma, according to a presentation at ASCO Annual Meeting.
Y chromosome loss may be key to unlocking more effective bladder cancer treatment for men
A series of studies showed that loss of the Y chromosome helps cancer evade the body’s immune system response, resulting in more aggressive bladder cancer in men as they age.
Approach predicts response to cisplatin among patients with cancer
A gene signature model appeared to predict response to cisplatin chemotherapy among tumor samples from patients with muscle-invasive bladder cancer, according to early-phase study results.
VIDEO: Automated tumor contact surface area scores concur with human-generated scores
In this video, Nour Abdallah, MD, discusses an abstract presented at American Urological Association Annual Meeting that investigated tumor contact surface area score and the potential use of artificial intelligence models in kidney cancer.
No genomic biomarkers of PFS-2 for RCC patients on immunotherapy-based combination therapies
CHICAGO — Researchers were unable to identify a discrete genomic biomarker of PFS after second line of therapy to help guide first-line regimen selection for patients with advanced clear cell renal cell carcinoma, according to a poster presentation at ASCO Annual Meeting.
Kidney cancer mortality rates decrease across US in past 2 decades
CHICAGO —Age-adjusted mortality rates in kidney cancer have decreased across all genders, races and ethnicities and in most states in the U.S. over the past 2 decades,according to a poster presentation at ASCO Annual Meeting.
VIDEO: AI produces accurate data on postoperative glomerular filtration rates
In this video, Nour Abdallah, MD, discusses an abstract from American Urological Association Annual Meeting on the use of artificial intelligence to predict the postoperative glomerular filtration rate after partial or radical nephrectomy.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read